{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:27:57Z","timestamp":1762507677302,"version":"3.44.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.exppara.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T11:56:00Z","timestamp":1552910160000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB\/c mice"],"prefix":"10.1016","volume":"200","author":[{"given":"Seyedeh Alia","family":"Moosavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-6828","authenticated-orcid":false,"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2019.03.004_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0163-7258(83)90010-4","article-title":"Delivery of liposome-encapsulated drugs to macrophages","volume":"22","author":"Alving","year":"1983","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exppara.2019.03.004_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/abbi.2001.2458","article-title":"Cationic liposomes induce macrophage apoptosis through mitochondrial pathway","volume":"392","author":"Aramaki","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.exppara.2019.03.004_bib3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.febslet.2010.01.055","article-title":"Involvement of protein kinase Cdelta in induction of apoptosis by cationic liposomes in macrophage-like RAW264.7 cells","volume":"584","author":"Arisaka","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exppara.2019.03.004_bib4","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/AAC.00524-10","article-title":"Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation","volume":"55","author":"Banerjee","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2012.06.004","article-title":"Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB\/c mice","volume":"124","author":"Bavarsad","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2019.03.004_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","article-title":"Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes","volume":"31","author":"Beach","year":"1988","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.004_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08982100903015025","article-title":"Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis","volume":"20","author":"Carneiro","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.exppara.2019.03.004_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/erv.11.17","article-title":"Cationic liposomes as vaccine adjuvants","volume":"10","author":"Christensen","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.exppara.2019.03.004_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00436-017-5716-3","article-title":"Performance of two immunochromatographic tests for diagnosis of visceral leishmaniasis in patients coinfected with HIV","volume":"117","author":"da Silva","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2019.03.004_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2015\/815023","article-title":"Advances in development of new treatment for leishmaniasis","volume":"2015","author":"de Menezes","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.exppara.2019.03.004_bib11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/AAC.44.6.1739-1742.2000","article-title":"Antileishmanial activities of stearylamine-bearing liposomes","volume":"44","author":"Dey","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/hs.2016.0054","article-title":"Refugees of the Syrian civil war: impact on reemerging infections, Health services, and biosecurity in Turkey","volume":"14","author":"Doganay","year":"2016","journal-title":"Health Secur"},{"key":"10.1016\/j.exppara.2019.03.004_bib13","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib14","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/jac\/dks164","article-title":"Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old world cutaneous leishmaniasis and refugee crises in the Middle East and north africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2019.03.004_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1081\/DDC-120030423","article-title":"In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis","volume":"30","author":"Ferreira","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.exppara.2019.03.004_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/0378-6323.175918","article-title":"Lack of efficacy of liposomal glucantime in the treatment of cutaneous leishmaniasis","volume":"82","author":"Ghoyonlo","year":"2016","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.exppara.2019.03.004_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2011.03.049","article-title":"Liposome surface charge influence on skin penetration behaviour","volume":"411","author":"Gillet","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2019.03.004_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/17425247.2011.574610","article-title":"Charged liposomes as carriers to enhance the permeation through the skin","volume":"8","author":"Gonzalez-Rodriguez","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.exppara.2019.03.004_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.apjtm.2017.10.016","article-title":"Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: an update","volume":"10","author":"Guti\u00e9rrez-Rebolledo","year":"2017","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"10.1016\/j.exppara.2019.03.004_bib21","doi-asserted-by":"crossref","first-page":"120462","DOI":"10.1155\/2011\/120462","article-title":"Inhibition of the growth of plasmodium falciparum in culture by stearylamine-phosphatidylcholine liposomes","volume":"2011","author":"Hasan","year":"2011","journal-title":"Journal of Parasitology Research"},{"key":"10.1016\/j.exppara.2019.03.004_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1189\/jlb.0405181","article-title":"Cationic liposomes induce apoptosis through p38 MAP kinase-caspase-8-Bid pathway in macrophage-like RAW264.7 cells","volume":"79","author":"Iwaoka","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.exppara.2019.03.004_bib23","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.01319-08","article-title":"Effect of topical liposomes containing paromomycin sulfate in the course of leishmania major infection in susceptible BALB\/c mice","volume":"53","author":"Jaafari","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exppara.2014.04.013","article-title":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice","volume":"143","author":"Kalat","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.004_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New world and old world leishmania infections: a practical review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.exppara.2019.03.004_bib26","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2019.03.004_bib27","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JCM.01733-09","article-title":"Evaluation of blood agar microtiter plates for culturing <em>Leishmania<\/em> parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis","volume":"48","author":"Maurya","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.exppara.2019.03.004_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/inthealth\/ihu037","article-title":"Neglected tropical diseases: now more than just 'other diseases'-the post-2015 agenda","volume":"6","author":"Molyneux","year":"2014","journal-title":"Int Health"},{"key":"10.1016\/j.exppara.2019.03.004_bib29","first-page":"253","article-title":"Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam","volume":"37","author":"New","year":"1980","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2019.03.004_bib30","first-page":"8679174","article-title":"A review on emerging and reemerging of infectious diseases in Jordan: the aftermath of the Syrian crises","volume":"2018","author":"Nimer","year":"2018","journal-title":"Can. J. Infect Dis. Med. Microbiol. J. Can. Des. Mal. Infect. et de la Microbiol. M\u00e9d."},{"key":"10.1016\/j.exppara.2019.03.004_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14787210.2016.1177457","article-title":"The Syrian conflict and infectious diseases","volume":"14","author":"Ozaras","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.exppara.2019.03.004_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08982104.2014.899368","article-title":"Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development","volume":"24","author":"Palac","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.exppara.2019.03.004_bib33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01796-15","article-title":"Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of plasmodium falciparum in culture and P. Berghei infection in murine malaria","volume":"60","author":"Rajendran","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017376","article-title":"Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant leishmania donovani in BALB\/c mice","volume":"6","author":"Roychoudhury","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2019.03.004_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630152607899","article-title":"Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis","volume":"12","author":"Salmanpour","year":"2001","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.exppara.2019.03.004_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1166\/jbn.2012.1385","article-title":"Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies","volume":"8","author":"Santos","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2019.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004438","article-title":"War and infectious diseases: challenges of the Syrian civil war","volume":"10","author":"Sharara","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.exppara.2019.03.004_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1988.tb07100.x","article-title":"Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony","volume":"119","author":"Sharquie","year":"1988","journal-title":"Br. J. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.exppara.2019.03.004_bib39","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2019.03.004_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2004.11.020","article-title":"Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle\u2013skin interaction","volume":"103","author":"Sinico","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.exppara.2019.03.004_bib41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"Solomon","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.exppara.2019.03.004_bib42","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JCM.01465-15","article-title":"A correlative study of splenic parasite score and peripheral blood parasite load estimation by quantitative PCR in visceral leishmaniasis","volume":"53","author":"Sudarshan","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.exppara.2019.03.004_bib43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/AAC.32.7.966","article-title":"In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes","volume":"32","author":"Tachibana","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2307\/3282665","article-title":"Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes","volume":"76","author":"Tachibana","year":"1990","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.004_bib45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/A:1024441702398","article-title":"Physicochemical properties of liposomes affecting apoptosis induced by cationic liposomes in macrophages","volume":"20","author":"Takano","year":"2003","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.exppara.2019.03.004_bib46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-4362.1996.tb03669.x","article-title":"Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate","volume":"35","author":"Tallab","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.exppara.2019.03.004_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2019.03.004_bib48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"Uzun","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.004_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02419-17","article-title":"Topical treatment for cutaneous leishmaniasis: dermato-pharmacokinetic lead optimization of benzoxaboroles","volume":"62","author":"Van Bocxlaer","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.004_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","article-title":"Particle size of liposomes influences dermal delivery of substances into skin","volume":"258","author":"Verma","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2019.03.004_bib51","first-page":"142","article-title":"Cutaneous leishmaniasis in subtropical Ecuador: popular perceptions, knowledge, and treatment","volume":"28","author":"Weigel","year":"1994","journal-title":"Bull. Pan Am. Health Organ."},{"key":"10.1016\/j.exppara.2019.03.004_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Weng","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.exppara.2019.03.004_bib53","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/0024-3205(87)90005-1","article-title":"Trypanocidal activity of the stearylamine-bearing liposome in vitro","volume":"40","author":"Yoshihara","year":"1987","journal-title":"Life Sci."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418304697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418304697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:25:04Z","timestamp":1758003904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489418304697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":53,"alternative-id":["S0014489418304697"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2019.03.004","relation":{},"ISSN":["0014-4894"],"issn-type":[{"type":"print","value":"0014-4894"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}